Meeting; State, Tribal, Local and Territorial (STLT) Subcommittee, Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC), 42525-42526 [2013-16965]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 136 / Tuesday, July 16, 2013 / Notices
Æ Are there uniform and recognized
differences in the lengths of rental and
leasing agreements? Do these lead to
special funding considerations for the
government?
Æ Are there specific differences in
other terms and conditions, such as
maintenance, warranty, insurance,
taxes, storage, and transportation? What
are the specific distinctions?
• FAR 7.402(a) and (b) provide
circumstances indicating when the
purchase or lease method is appropriate.
Should rent be added as a third method?
If so, when is renting a more appropriate
method than purchasing or leasing and
in what way would it impact the
determination of most effective
procurement approach (e.g., cost savings
and efficiencies)?
• Does short-term rental offer cost
savings and efficiencies unavailable
through leasing?
• What additional guidance might be
provided at FAR subpart 7.4 to clarify
when and how to perform the required
analysis?
Dated: July 9, 2013.
William Clark,
Acting Director, Federal Acquisition Policy
Division, Office of Governmentwide
Acquisition Policy, Office of Acquisition
Policy, Office of Governmentwide Policy.
[FR Doc. 2013–16920 Filed 7–15–13; 8:45 am]
BILLING CODE 6820–14–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting; Subcommittee for Dose
Reconstruction Reviews, Advisory
Board on Radiation and Worker Health
(ABRWH or the Advisory Board),
National Institute for Occupational
Safety and Health (NIOSH)
emcdonald on DSK67QTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 10:00 a.m.–5:00 p.m.,
Eastern Time, August 7, 2013.
Place: Audio Conference Call via FTS
Conferencing. The USA toll-free, dial-in
number is 1–866–659–0537, and the pass
code is 9933701.
Status: Open to the public, but without an
oral public comment period.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000, to advise the President on a
variety of policy and technical functions
required to implement and effectively
VerDate Mar<15>2010
18:49 Jul 15, 2013
Jkt 229001
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that have
been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction, which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort.
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2013.
Purpose: The Advisory Board is charged
with (a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class. The Subcommittee for Dose
Reconstruction Reviews was established to
aid the Advisory Board in carrying out its
duty to advise the Secretary, HHS, on dose
reconstruction.
Matters To Be Discussed: The agenda for
the Subcommittee meeting includes: dose
reconstruction program quality management
and assurance activities, including current
findings from NIOSH internal dose
reconstruction blind reviews; and discussion
of dose reconstruction cases under review
(sets 8–9, and Savannah River Site, Rocky
Flats Plant, and Los Alamos National
Laboratory cases from sets 10–13).
The agenda is subject to change as
priorities dictate.
In the event an individual cannot attend,
written comments may be submitted. Any
written comments received will be provided
at the meeting and should be submitted to
the contact person below well in advance of
the meeting.
Contact Person for More Information:
Theodore Katz, Designated Federal Official,
NIOSH, CDC, 1600 Clifton Road, Mailstop E–
20, Atlanta, Georgia 30333, Telephone: (513)
533–6800, Toll Free 1 (800) CDC–INFO,
Email: ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
42525
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dana Redford,
Acting Director, Management Analysis and
Services Office Centers for Disease Control
and Prevention.
[FR Doc. 2013–16964 Filed 7–15–13; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting; State, Tribal, Local and
Territorial (STLT) Subcommittee,
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
Time and Date: 8:30 a.m.–4:00 p.m., EDT,
August 9, 2013.
Place: CDC, Building 19, Rooms 254 and
255, 1600 Clifton Road NE., Atlanta, Georgia
30333.
Status: Open to the public, limited only by
the space available. The meeting rooms
accommodate approximately 20 people. The
public is welcome to participate during the
public comment period, which is tentatively
scheduled from 3:15 p.m. to 3:35 p.m. This
meeting will also be available by
teleconference. Please dial (888) 233–0592
and enter code 33288611.
Purpose: The Subcommittee will provide
advice to the CDC Director through the ACD
on strategies and future needs and challenges
faced by State, Tribal, Local and Territorial
health agencies, and will provide guidance
on opportunities for CDC.
Matters To Be Discussed: The STLT
Subcommittee members will discuss
implementation of ACD-adopted
recommendations related to the health
department of the future and how CDC can
best support STLT health departments.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information: Judy
Monroe, M.D., Designated Federal Officer,
STLT Subcommittee—ACD, CDC, 1600
Clifton Road, NE., M/S E–70, Atlanta,
Georgia 30333, Telephone: (404) 498–0300,
Email: OSTLTSDirector@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
E:\FR\FM\16JYN1.SGM
16JYN1
42526
Federal Register / Vol. 78, No. 136 / Tuesday, July 16, 2013 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dana Redford,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013–16965 Filed 7–15–13; 8:45 am]
Dated: July 10, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013–16973 Filed 7–15–13; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Food and Drug Administration
Compliance Policy Guide Sec. 690.800
Salmonella in Food for Animals;
Availability
[Docket No. FDA–2010–D–0378]
[Docket No. FDA–2013–D–0254]
Salmonella Contamination of Dry Dog
Food; Withdrawal of Compliance
Policy Guide
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; Withdrawal.
The Food and Drug
Administration (FDA) is announcing the
withdrawal of the compliance policy
guide (CPG) entitled ‘‘Sec. 690.700
Salmonella Contamination of Dry Dog
Food.’’ This CPG is obsolete.
DATES: The withdrawal is effective July
16, 2013.
FOR FURTHER INFORMATION CONTACT:
Diane D. Jeang, Office of Regulatory
Affairs, Food and Drug Administration,
12420 Parklawn Dr., Rockville, MD
20857, 301–796–3890.
SUPPLEMENTARY INFORMATION: FDA
issued the CGP entitled ‘‘Sec. 690.700
Salmonella Contamination of Dry Dog
Food (CPG 690.700)’’ on October 1,
1980. CPG 690.700 was issued as a
result of a human case of salmonellosis
traced to dry dog food; a subsequent
FDA-conducted survey of dry dog food;
a risk analysis; and the development of
an appropriate sampling technique to
test dry dog food for salmonella
organisms.
Elsewhere in this issue of the Federal
Register, FDA is announcing the
availability of a new CPG to address all
food for animals that may contain
salmonella organisms, including dry
dog food. This new CPG, entitled
‘‘Compliance Policy Guide Sec. 690.800
Salmonella in Food for Animals,’’
supersedes CPG 690.700 and makes CPG
690.700 obsolete. The notice of
availability for CPG ‘‘Sec. 690.800
Salmonella in Food for Animals’’ is
published elsewhere in this issue of the
Federal Register.
FDA is withdrawing CPG 690.700, in
its entirety, to eliminate obsolete
compliance policy.
emcdonald on DSK67QTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
18:49 Jul 15, 2013
Jkt 229001
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or we) is
announcing the availability of guidance
for our staff entitled ‘‘Compliance Policy
Guide Sec. 690.800 Salmonella in Food
for Animals’’ (the CPG). The CPG
provides guidance to FDA staff on
Salmonella-contaminated food for
animals.
DATES: Submit either electronic or
written comments on the CPG at any
time.
ADDRESSES: Submit written requests for
single copies of the CPG to the Food and
Feed Policy Staff, Office of Policy and
Risk Management, Office of Regulatory
Affairs, Food and Drug Administration,
12420 Parklawn Dr., Rockville, MD
20850. Send one self-addressed
adhesive label to assist that office in
processing your request. See the
SUPPLEMENTARY INFORMATION section for
electronic access to the CPG.
Submit electronic comments on the
CPG to https://www.regulations.gov.
Submit written comments on the CPG to
the Division of Dockets Management
(HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Kim
Young, Center for Veterinary Medicine
(HFV–230), Food and Drug
Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240–276–9207,
kim.young@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background
We are announcing the availability of
a guidance document entitled
‘‘Compliance Policy Guide Sec. 690.800
Salmonella in Food for Animals’’ (the
CPG). The CPG provides guidance to
FDA staff on Salmonella-contaminated
food for animals. The CPG is being
issued consistent with our good
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
guidance practices regulation (21 CFR
10.115). The CPG represents FDA’s
current thinking on Salmonellacontaminated food for animals. It does
not create or confer any rights for or on
any person and does not operate to bind
FDA or the public. An alternative
approach may be used if such approach
satisfies the requirements of the
applicable statutes and regulations.
In the Federal Register of August 2,
2010 (75 FR 45130), we announced the
availability of a draft CPG entitled
‘‘Compliance Policy Guide Sec. 690.800
Salmonella in Animal Feed,’’ and gave
interested persons an opportunity to
submit comments by November 1, 2010,
for us to consider before beginning our
work on the final version of the CPG. In
the Federal Register of October 29, 2010
(75 FR 66769), we published a notice
extending the comment period until
December 31, 2010. We received
numerous comments on the draft CPG
and have modified the final CPG where
appropriate. The CPG announced in this
notice finalizes the draft CPG
announced on August 2, 2010.
Changes to the CPG include:
• The title of the CPG is changed from
‘‘Salmonella in Animal Feed’’ to
‘‘Salmonella in Food for Animals.’’ FDA
made this change to clarify that the CPG
covers all animal food. The term ‘‘food
for animals’’ here includes pet food and
animal feed.
• The term ‘‘Direct Human Contact
Animal Feed’’ has been removed from
the CPG, because commenters found the
term to be confusing. The term pet food
is now used instead. It is defined to
mean food for pets and includes treats
and chews for pets.
The CPG explains criteria that FDA
personnel should consider in
recommending enforcement action
against food for animals that is
adulterated due to the presence of
Salmonella. In particular, the CPG
provides regulatory action guidance
relating to pet food or pet food
ingredients that are contaminated with
Salmonella. In addition, the CPG
provides regulatory action guidance
relating to animal feed and animal feed
ingredients that are contaminated with
certain Salmonella serotypes that are
pathogenic to the particular species of
animal for which the animal feed or
animal feed ingredients are intended.
The CPG also contains information that
may be useful to regulated industry and
the public.
This notice is related to two notices
published elsewhere in this issue of the
Federal Register, in which FDA is
announcing: (1) The removal of 21 CFR
500.35 ‘‘Animal feeds contaminated
with Salmonella microorganisms,’’ and
E:\FR\FM\16JYN1.SGM
16JYN1
]]>Agencies
[Federal Register Volume 78, Number 136 (Tuesday, July 16, 2013)]
[Notices]
[Pages 42525-42526]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-16965]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting; State, Tribal, Local and Territorial (STLT)
Subcommittee, Advisory Committee to the Director (ACD), Centers for
Disease Control and Prevention (CDC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
subcommittee:
Time and Date: 8:30 a.m.-4:00 p.m., EDT, August 9, 2013.
Place: CDC, Building 19, Rooms 254 and 255, 1600 Clifton Road
NE., Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
The meeting rooms accommodate approximately 20 people. The public is
welcome to participate during the public comment period, which is
tentatively scheduled from 3:15 p.m. to 3:35 p.m. This meeting will
also be available by teleconference. Please dial (888) 233-0592 and
enter code 33288611.
Purpose: The Subcommittee will provide advice to the CDC
Director through the ACD on strategies and future needs and
challenges faced by State, Tribal, Local and Territorial health
agencies, and will provide guidance on opportunities for CDC.
Matters To Be Discussed: The STLT Subcommittee members will
discuss implementation of ACD-adopted recommendations related to the
health department of the future and how CDC can best support STLT
health departments.
The agenda is subject to change as priorities dictate.
Contact Person for More Information: Judy Monroe, M.D.,
Designated Federal Officer, STLT Subcommittee--ACD, CDC, 1600
Clifton Road, NE., M/S E-70, Atlanta, Georgia 30333, Telephone:
(404) 498-0300, Email: OSTLTSDirector@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and
[[Page 42526]]
Prevention and the Agency for Toxic Substances and Disease Registry.
Dana Redford,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2013-16965 Filed 7-15-13; 8:45 am]
BILLING CODE 4163-18-P
